Bought $4,000 (~10% model portfolio) XBI @ $89.31 Stop @ $61.89 The Biotech industry, understandably rallied sharply in 2020 once the Covid lows had been made. Perhaps too sharply as it turns out. Since reaching a high in early 2021, XBI (balanced Biotech ETF) has underperformed significantly. It is now trading well below pre-Covid levels and has actually fallen all the way back to 2015 levels. We don’t believe this is properly valued at this … read more Buy-and-Hold Portfolio Trade Alert